Thai company inks biopharmaceutical technology pact with Cuban firm

Thai company inks biopharmaceutical technology pact with Cuban firm

April 29, 2014 5:03 pm



Thailand's first biopharmaceutical company on Tuesday signed a

technology transfer pact with Cuba's Center of Molecular Immunology to

produce drugs to treat cancer and autoimmune diseases.



The agreement was signed between the Siam Bioscience Company and the

Cuban centre, set up in 1994 to research and manufacture "off-patent

biopharmaceuticals."



The specialised medical field uses genetic engineering to produce new

medicines, most of which remain inaccessible to developing countries

because of their high production costs.



"In Cuba we made the first steps in biotechnology early in the

'80s,under the direct leadership of President Fidel Castro," said

Agustin Lage Devila, director general of the Center of Molecular Immunology.



"However, no country can face this enormous challenge alone," he said.

"International cooperation is needed, especially joint projects among

developing countries."



In Thailand, the centre agreed to make Siam Bioscience its contract

manufacturer of biopharmaceuticals to treat lymphoma, breast cancer and

autoimmune diseases, which include arthritis and multiple sclerosis.



DPA





Source: Thai company inks biopharmaceutical technology pact with Cuban

firm - The Nation -

http://www.nationmultimedia.com/breakingnews/Thai-company-inks-biopharmaceutical-technology-pac-30232519.html